04/19/2024
3:31 PM | Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024
3:31 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024
5:48 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:38 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:19 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/22/2024
8:21 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
6:50 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024
3:12 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:11 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024
3:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:14 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:59 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:03 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:34 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024
5:35 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:49 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:38 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:09 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024
4:48 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:37 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:39 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024
4:35 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:01 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
1:42 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:34 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:11 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
12:40 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:58 PM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
01/31/2024
4:00 PM | Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
01/17/2024
5:01 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:32 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:35 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
They say it’s ‘unstoppable’ – How I made 43,509% (Ad) Not long ago I joined Phil Ash for a private one-on-one interview.
And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015…
Without a single loss. Click here now for the full story. |
12/29/2023
3:36 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:06 PM | Arcellx, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13G/A | |
12/28/2023
4:09 PM | Arcellx, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
3:07 PM | Gilead Sciences (Reporting)
HOOKIPA Pharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
6:00 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:04 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:08 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:10 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:15 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
5:21 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:18 PM | Gilead Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
4:56 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2023
6:15 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
4:18 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D | |
10/19/2023
2:33 PM | Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
| Form SC 13G | |
10/18/2023
3:31 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:18 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023
7:09 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
8:00 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
5:50 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:21 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
7:37 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:40 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:44 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:19 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:09 PM | Gilead Sciences (Filer)
| Form 424B5 | |
09/07/2023
4:28 PM | Gilead Sciences (Subject)
| Form FWP | |
09/07/2023
7:29 AM | Gilead Sciences (Filer)
| Form 424B5 | |
08/16/2023
4:19 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
4:23 PM | Gilead Sciences (Filer)
| Form S-3ASR | |
07/25/2023
5:15 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
4:30 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
8:38 AM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/30/2023
2:54 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
2:12 PM | Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:17 PM | Allovir, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:48 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:29 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
3:45 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:50 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
10:15 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:10 PM | BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
6:15 PM | Gilead Sciences (Issuer)
Kramer Kelly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:02 PM | Gilead Sciences (Issuer)
Horning Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:13 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:47 PM | Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:51 PM | Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:53 PM | Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:57 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
They say it’s ‘unstoppable’ – How I made 43,509% (Ad) Not long ago I joined Phil Ash for a private one-on-one interview.
And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015…
Without a single loss. Click here now for the full story. |
05/02/2023
6:12 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
